Your Health, We Care
Lucius Pharmaceutical is focused on providing effective, safe, and reliable medications and services for patients all over the world. We have always believed in putting health first and prioritizing innovation, continually developing new drugs and improving treatment plans to meet the needs of patients globally.
As of June 2024, Lucius Pharmaceutical has approved the marketing of 54 anti-cancer drugs, including Sotorasib, Osimertinib, Cabozantinib, larotinib, Larotrectinib, Avatrombopag, Crizotinib, capmatinib, Lorlatinib, Capmatinib, Ivosidenib, and Gilteritinib, and more than 200 generic drug types.
With a global presence, Lucius Pharmaceutical has established strong partnerships in countries such as Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Brunei, Malaysia, Sri Lanka, Turkey, Japan, and China. Lucius Pharmaceuticals is dedicated to providing accessible and affordable medicines to people in need all over the world.
Founding Time ( Year )
Floor Area ( Centiare )
Partner ( Nation )
Types of drugs ( Kind )
